Racial differences found in emphysema onsetJuly 11, 2006Although African Americans smoke fewer cigarettes and inhale them less deeply than Caucasians, they contract emphysema at an earlier age, according to a study by Temple University researchers in the journal Chest. The study, which confirms findings from a smaller preliminary study published last year, also offers evidence of biological differences in the distribution of emphysema and the severity of lung destruction between African Americans and Caucasians, leading researchers to conclude that the mechanism underlying the disease might also vary between the races. "Not everyone who smokes gets emphysema or the same type of emphysema," says Wissam Chatila, MD, lead author and associate professor of medicine at Temple University School of Medicine and Hospital. "Our study supports previous findings that there might be something different between African Americans and Caucasians who are susceptible to the bad effects of smoking. The next question — why is this so?" While researchers begin to tackle this puzzle, Chatila notes that the current study contains important implications for primary care doctors of African American patients. By identifying the disease early and avoiding misdiagnosis, patients can receive better treatments and achieve improved outcomes. Along with an understanding of how severe emphysema develops, the work may also aid in shaping antismoking policies and smoking cessation programs that specifically target African Americans. "If African American patients are smoking and suffering some degree of breathing disturbances, the study shows that we need to pay better attention, even if they seem too young to have emphysema," said Chatila, who is also a pulmonary specialist at the Temple Lung Center. Confirmation of earlier findings on racial biological differences was important because of understandable skepticism about such distinctions. "People question whether racial differences in disease are due to factors such as the environment, socioeconomic status or health care disparities," says Chatila. The researchers acknowledge that such issues may play an important part in the development and onset of the disease and further, that a much higher proportion of African Americans will need to be studied before resolving issues of race and environment that might influence emphysema risks and outcomes. The Temple team examined 1198 patients with severe or very severe emphysema who were enrolled in the National Emphysema Treatment Trail (NETT). Severity, distribution and physiologic impact of emphysema in both groups were determined using cardiopulmonary function tests, quantitative computed tomography (CT) of the chest, and a quality of life questionnaire. Forty-two participants were African Americans (3.4%), compared to 1156 (95%) Caucasians. However, when matched in respect to age, height, smoking and pulmonary function, researchers were still surprised to find differences in how the disease progressed in the two races, in particular that African Americans were younger and smoked less than whites. The report notes that while "few doubt the answer lies in the complex genotype- environment interaction, the extent to which each factor plays a role in the development of emphysema remains enigmatic." Chatila, whose interest in this area of research originated when he and his colleagues noticed that African American patients were presenting with chronic obstructive pulmonary disease (COPD) that was often under treated and misdiagnosed, has already begun to explore the cellular differences and inflammation in patients with emphysema to see if these can explain some of the differences observed in the study. Temple University |
|||||||||||||||||||||
| Related Emphysema Current Events and Emphysema News Articles U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide. Stereotactic radiotherapy offers noninvasive, effective treatment for frail patients with early-stage lung cancer Stereotactic body radiation therapy (SBRT) should be considered a new standard of care for early-stage lung cancer treatment in patients with co-existing medical problems, according to results from a national clinical trial led by UT Southwestern Medical Center physicians. Survey: Awareness of COPD is rising, but understanding is still low Awareness of COPD-chronic obstructive pulmonary disease-continues to grow in the United States, according to national survey results released today by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. UT scientists discover link between protein and lung disease In a development that could lead to a novel approach to the treatment of a devastating lung disease, biochemists at The University of Texas Health Science Center at Houston report they are the first to link the osteopontin (OPN) protein to chronic obstructive pulmonary disease (COPD). New genes at work in patients with hereditary lung disease University of Florida researchers have safely given new, functional genes to patients with a hereditary defect that can lead to fatal lung and liver diseases, according to clinical trial findings slated to appear this week in the online early edition of the Proceedings of the National Academy of Sciences. New genes at work in patients with hereditary lung disease Researchers at the University of Massachusetts Medical School and the University of Florida in Gainesville have safely given new, functional genes to patients with a hereditary defect that can lead to fatal lung and liver diseases. Scientists open doors to diagnosis of emphysema Chronic inflammatory lung diseases like chronic bronchitis and emphysema are a major global health problem, and the fourth leading cause of death and disability in developed countries, with smoking accounting for 90% of the risk for developing them. Emphysema severity directly linked to coal dust exposure Coal dust exposure is directly linked to severity of emphysema in smokers and nonsmokers alike, according to new research from the National Institute for Occupational Safety and Health (NIOSH). Lung volume reduction surgery shown to prolong and improve life for some emphysema patients Lung volume reduction surgery (LVRS) can have a significantly beneficial effect in patients with severe emphysema, according to the first ever study to randomize emphysema patients to receive either LVRS or non-surgical medical care. Protein may be strongest indicator of rare lung disease, study shows Researchers at the University of Cincinnati (UC) have discovered a protein in the lungs that can help in determining progression of the rare lung disease Idiopathic Pulmonary Fibrosis (IPF). More Emphysema Current Events and Emphysema News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||